10 citations
,
June 2022 in “Frontiers in Immunology” This study found that sterile fucoidan promotes T cell proliferation but reduces differentiation at higher concentrations and suppresses osteogenic differentiation in co-cultured environments.
April 2023 in “Elsevier eBooks” This review discusses the various phenotypes and systemic manifestations of polycystic ovary syndrome, including metabolic, reproductive, and psychological aspects, but reports no new clinical results.
56 citations
,
January 2004 in “Journal of the American Academy of Dermatology” This case report describes a 34-year-old kidney transplant patient who developed a unique skin condition linked to cyclosporine, characterized by flesh-colored papules, and introduces "cyclosporine induced folliculodystrophy" as a term for this condition.
This study found no significant differences in length of stay, mechanical ventilation use, or mortality between hospitalized bronchiectasis patients with and without obstructive sleep apnea.
14 citations
,
December 2017 in “Journal of Bone and Mineral Metabolism” This study found that women with polycystic ovary syndrome had a higher risk of fractures, including osteoporotic and specific types like spine and forearm fractures, compared to those without the condition.
June 2008 in “Society for the Study of Human Biology” This paper discusses the evolution of the clinical understanding of polycystic ovary syndrome, noting its association with anovulatory infertility and varied diagnostic criteria, but reports no new clinical findings.
22 citations
,
March 1963 in “Archives of dermatology” This case report describes hair regrowth in a patient with alopecia totalis using fluocinolone acetonide cream applied under thin plastic films.
May 2023 in “International Journal of Home Science” This survey reported that 95% of respondents were aware of polycystic ovary syndrome, highlighting a high level of awareness about PCOS among the participants.
2 citations
,
July 2023 in “Frontiers in Endocrinology” This review identified and evaluated polycystic ovary syndrome models of care, finding that only three fully aligned with international guidelines and generally received positive feedback on satisfaction; just one showed an impact on patients' BMI.
November 2018 in “Chin J Clin Lab Mgt (Electronic Edition)” This paper introduces Concentration Growth Factor (CGF) as a potential treatment for androgenetic alopecia, but reports no clinical findings on its effectiveness in promoting hair growth.
1 citations
,
April 2025 in “JOJ Dermatology & Cosmetics” In this study, researchers evaluated the efficacy of a collagen booster used alongside CO2 fractional laser treatment for skin aging, finding that the combination treatment affected the vascularization and healing process of the skin on a healthy adult's forearm.
November 2025 in “Gynecological Endocrinology” This review discusses coordinated management strategies for polycystic ovary syndrome across various levels of care but reports no new clinical results.
1 citations
,
July 2022 in “Zenodo (CERN European Organization for Nuclear Research)” This paper discusses the role of food and exercise in managing polycystic ovarian syndrome and reports no new results.
November 2018 in “International Journal of Current Pharmaceutical Research” This review discusses the causes, underlying mechanisms, diagnosis, and treatment strategies for polycystic ovary syndrome but reports no new clinical findings.
April 2020 in “Research Square (Research Square)” This study found that oral contraceptives containing cyproterone acetate improved the overall quality of life in PCOS patients more than those containing levonorgestrel after 6 months of treatment.
13 citations
,
October 2011 in “Clinical Obstetrics and Gynecology” This review covers the diagnosis of polycystic ovary syndrome and the management of related infertility, describing evaluation and initial treatment steps, without presenting new clinical results.
4 citations
,
October 2023 in “Children” This study diagnosed a group of six girls with various ectodermal abnormalities, identifying cranio-skeletal malformations consistent with focal dermal hypoplasia (Goltz syndrome), and found heterozygous mutations in the PORCN gene in two children.
August 2025 in “Obstetrics and gynecology.” This article reviews the management of polycystic ovarian syndrome, highlighting lifestyle modification and individualized pharmacological treatment strategies, and reports no new clinical results.
February 1978 in “PubMed” This article reviews hair loss associated with oral contraceptive use and suggests that while diffuse effluvium is usually harmless, androgenetic alopecia caused by certain contraceptive types requires a change in medication; no new clinical results are reported.
April 2026 in “AMEI's Current Trends in Diagnosis & Treatment” This review discusses the symptoms, causes, and treatment options for polycystic ovary syndrome and reports no new results; the authors highlight the role of lifestyle changes, medications, and fertility treatments.
3 citations
,
April 2018 in “Journal of Investigative Dermatology” CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.
May 2024 in “Internattional journal of current innovation in advance research” This review discusses PCOD, highlighting its hormonal abnormalities and contributing factors, such as lifestyle and genetics. The authors emphasized that lifestyle changes and medications are central to effectively managing symptoms and improving fertility in impacted women.
1 citations
,
October 2023 in “The Laryngoscope” In this study, single-port endoscopic removal of forehead osteoma in adult patients showed complete tumor removal with excellent cosmetic results, highlighting otolaryngologists' expertise in minimally invasive techniques and achieving low surgical morbidity.
1 citations
,
December 2020 in “Journal of diabetes and endocrine practice” I'm sorry, but I can't provide a summary without the content of the document.
December 2025 in “Egyptian Journal of Basic and Applied Sciences” This study observed that FOXA1 and CCL2 gene expression levels were significantly elevated in women with different PCOS phenotypes compared to healthy controls, indicating phenotype-specific molecular variations which could inform personalized treatment strategies for infertility in PCOS.
8 citations
,
February 2010 in “Journal für Kardiologie (Krause & Pachernegg GmbH)” This study developed a detailed classification system for functional androgenization in females that may enhance diagnosis and personalized treatment by identifying individual dysfunctions.
August 2020 in “Journal of Shahid Sadoughi University of Medical Sciences” This review discusses the role of oxidative stress in polycystic ovary syndrome and reports no new clinical results; the authors highlight the importance of understanding these mechanisms for prevention and treatment strategies.
6 citations
,
May 2012 in “The Journal of Dermatology” This letter reports on a case of intractable ophiasis-type alopecia areata that was presumably improved by fexofenadine, but no new clinical results are presented.
1 citations
,
March 2024 in “Türk Kadın Sağlığı ve Neonatoloji Dergisi” This study concluded that among patients with polycystic ovary syndrome at their clinic, the most common phenotype was group A, with lifestyle modification and oral contraceptives being frequently used treatments.
22 citations
,
January 2002 in “Treatments in endocrinology” This review examines the role of androgens in cutaneous disorders and the potential therapeutic effects of different oral contraceptives, noting variations in individual responses and the influence of genetic and local factors but reports no new clinical results.